- 8 health system, hospital CMO and CNO exits in 2026
- 10 new medical schools announced in 2026
- Physician-owned assisted living facility opens in Utah
- Leadership in the Age of Learning
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- Massachusetts moves to restrict kratom sales
- 1 dead in officer-involved shooting at Alabama hospital campus
- Cyclosporiasis admissions top 700: 4 things to know
- The value of ‘prosocial grand ambition’
- Meet the leaders of the fastest-growing dental practices
- WISeR’s high-stakes first year, in 8 questions
- Health system CEO pay in 2026: 6 trends to know
- 10 states with the biggest population gains and losses
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Will cardiology’s ASC strategy pay off? CVL’s new CEO is betting on it
- 5 numbers making dentists optimistic
- 25 state behavioral health policy updates
- Wisconsin woman accused of posing as fake dentist ordered to pay customer $144K
- Physician independence is making a comeback — why ASCs are leading the way
- Surgery Partners is betting on physician recruiting, not M&A, for growth: 5 things to know
- Dentists battle insurance woes: 5 updates
- Philadelphia dentist dies at 86
- 4 injured after car crashes into North Carolina pediatric dental office
- Ellis Hospital sues St. Peter’s over cardiologist noncompetes, warns of $75M revenue risk
- Mental healthcare provider gaps, by state
- Park Dental Partners posts $66.2M in Q2 revenue
- 28 new behavioral health study findings to know
- 23 new behavioral health projects to know
- Which services are hit hardest by CON?
- 5 gastroenterologists in the headlines
- Where spine, orthopedic ASCs are gaining ground
- Aspen Dental continues 2026 growth with new Chicago practice
- Major PBMs agree to offer TrumpRx pricing information to members
- Distalmotion gets FDA clearance for hernia repair system
- NYC Health + Hospitals adds $600K ophthalmology microscope
- Providence reports $400M operating improvement halfway through 2026
- A look at where Aetna is seeing value-based care success in Medicare Advantage
- Nationwide program to quit smoking would save US $12B: Study
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- Angelalign to appeal court’s decision in clear aligner patent infringement case
- It's crunch time for Karyopharm as company faces potential default next month
- UNC Health Pardee completes 23-bed behavioral health center
- Oregon State Hospital superintendent out after less than a month
- Nebraska ASC inks prime vendor agreement with Medline
- Affordable Care completes recapitalization, enters ‘next chapter’ of growth
- March of Dimes: Maternity care deserts persist, Medicaid cuts threaten to curb access further
- Trump administration refers scores of providers, pharmacies, PBMs to DOJ, OIG over past billing for pediatric gender-affirming care
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- Obesity not a 'zero-sum game' as patients crave optionality, Novo CEO says: Reuters
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- Abbott to pump up blood supply with $1M college sports prize amid US crisis
- Federal agencies release ‘Treatment First’ toolkit
- California moves 15 behavioral health projects forward
- Neurocrine stands by blockbuster hopeful Vykat XR as Prader-Willi docs raise potential safety flags
- Appeals court tosses methodology for calculating NSA qualifying payment amounts
- UC San Diego Health, West Health launch $40M accelerator for 'tech-forward' coordinated care
- Epic releases Care Everywhere diagnostic image exchange to tackle healthcare's 'CD problem'
- FDA Wants More Information From Food Makers On New Food Chemicals
- Cityblock unveils partnership with Humana in North Carolina
- Antelope Recovery, offering SUD care for teens, to expand Spanish services in Colorado
- Legend interim CEO talks rising competition as Carvykti maker posts first profit
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Cedar launches Kora Platform to build out agentic AI for medical billing
- Sharp HealthCare announces another reorganization affecting 260 workers
- Alfasigma gains arthritis drug, access to new markets with M&A play
- Common Health Coalition secures $100M from OpenAI Foundation to boost hepatitis C cure rates
- Lilly takes 6 companies to court for selling retatrutide knockoffs
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Suvi Health launches ambient AI solution for patients to reduce hospital stays and support care transitions
- The biggest payer and provider trends from Q2
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Hospitals Say They Found a Tool To Help Reduce Childbirth Risks: Wristbands
- Years After He Quit Smoking, a Lung Cancer Scan Saved His Life
- Hospital Prepayment Requirements Add New Wrinkles to Patients’ Financial Responsibility
- Fresenius pulls one batch of Actemra biosim over glass particle concerns
- Oracle Health debuts revamped patient portal with an AI upgrade
- Snapchat creates ad format to support pharma disclosure needs
- CMS ends Medicaid, CHIP funding for gender-affirming care for minors
- Healthcare CFOs face growing decision-making expectations. Many say they aren't ready
- Assort Health rolls out AI agent to automate referrals for specialty practices and health systems
- Claims data transparency empowers employers to act on affordability: survey
- Hims & Hers posts $753M in Q2 revenue as it preps for push into peptide market
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Senators introduce bipartisan legislation to further antimicrobial resistance research
- CMS' mandatory VBC programs brought substantial administrative costs for hospitals: study
- Flagler Health secures $50M series B for AI-native MSK care platform expansion
- Attruby cruises toward blockbuster land as BridgeBio CEO spots ‘stabilizer-first’ ATTR market
- WuXi AppTec scores temporary win amid fight over DOD's Chinese military company brand
- Barbie And Ken Fade From Fantasy, Offer More Realistic Proportions, Study Finds
- Children Should Get Flu Vaccine, Top Pediatrics Group Recommends
- Together, Two Everyday Health Factors Double Death Risk In Midlife And Beyond
- Many States Cover Doula Care, But Access To A 'Birthing Bestie' Is Often Out Of Reach
- Patients Wary of Governments, Companies Pushing AI as a Rural Healthcare Solution
- A Federal Policy Is Complicating How Organizations Battle the Opioid Crisis
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- Trump signs executive order to overhaul pediatric vaccine recommendations
- Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path
- Jalapeño Recall Reaches Seven Grocery Chains In 26 States
- New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval
- Even Light Exercise May Lower Stroke Risk For People With A-fib
- Working At Home Makes Breastfeeding Harder, Not Easier, Study Says
- Kidney Dialysis: Here's What You Need To Know
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
- Abbott casts telenovela star Gabriela Spanic to take the drama out of colon cancer screening
- Bristol Myers Squibb lays out plan for $2.3B manufacturing facility in Houston
- Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug
- Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics
- Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's
- Budget Battle Erupts In Nation's Capital Over Opioid Settlement Money
- Rising Global Heat Linked To Mental Health Risks In Children
- Quanterix hires GE Healthcare, Exact Sciences alum as chief commercial officer
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- FDA Reverses Course, Approves First mRNA Flu Shot
- Therapy Dogs Aid Stroke Rehab
- Can Yoga Calm A Grumpy Gut?
- Review Finds Little Proof IVF Embryo Transfer Tricks Boost Success
- Short-Term Vegan Diet Linked To Lower Inflammation And Aging
- Medicaid Work Rule Leaves Homeless People In The Cold
- Wildfire Smoke An Increasing Hazard To U.S. Pregnancies, Study Says
- Salmonella Outbreak Linked To Imported Jalapeños Sickens Hundreds
- Leo Pharma readies rare disease education push for 2nd annual GPP awareness day
- Wildfire Smoke Sends More Oregonians To Emergency Rooms
- Peanut Allergy? Fecal Transplant Might Be A Solution, Pilot Trial Finds
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
Michigan healthcare freedom community forum
We've heard enough whiz-bang health reform ideas out of Washington, D.C. to earn the right of cynics everywhere to yawn and go do something effective like washing dishes.
Here Real Clear Policy delivers a Congressional assessment with enough substance, I'm tempted to actually follow it.
We'll see.
The Right Rx on Health Policy: a Strong House Performance
After enacting a pro-patient, pro-consumer health care agenda that could expand personal choices and lower costs, House Speaker Kevin McCarthy (R-CA) and his leadership team deserve credit. From expanding access to affordable health coverage for small businesses to ensuring price transparency for medical services and requiring Medicare to pay the same for certain procedures, whether they are delivered in a hospital setting or a doctor’s office, the Speaker’s targeted approach is starting to bear fruit.
The recently enacted Choice Arrangement Act (H.R. 3799), sponsored by Rep. Kevin Hern (R-OK), is a prime example. Heading to the Senate after being passed by a vote of 220 to 209, Rep. Hern’s bill directly addresses the problems of small businesses and their workers who have no options if they cannot afford the current cost of group employment coverage.
Under the bill, small employers would be able to band together—whether they are in the same industry or not—to create an “association health plan” and a large insurance pool that would empower employers to negotiate lower premiums and out-of- pocket costs for their employees. It would also enable them to customize their benefit offerings, which would reduce employee premium costs.
Rep. Hern’s bill also allows employers to provide individual coverage health reimbursement arrangements (ICHRAs) for their workers. Under these arrangements, employers can make tax-free contributions to special accounts that workers can then use to buy individual health insurance with tax-free premiums. That means that workers and their families would be able to enroll in the kind of health plans that they want, but without companies imposing lifetime caps or denying people coverage for preventive medical services.
Overall, the bill expands private coverage options for workers and businesses—something that the ACA and other government-run health programs fail to do. Perhaps that’s why the National Federation of Independent Business (NFIB), representing small businesses, strongly supports the bill. It certainly helps explain why the Biden administration strongly opposes it.
Meanwhile, in a refreshing break from intense partisan polarization, Rep. Cathy McMorris Rogers (R-WA), chair of the House Energy and Commerce Committee, has been working closely with ranking minority leader Rep. Frank Pallone (D-NJ) to secure bipartisan support for a half dozen health-related bills that will soon be schedule for House floor, debate, and passage.
Perhaps the most significant for patients are the provisions of H.R. 3561, The Patient Act, which reinforces existing regulations related to promoting transparency. More specifically, the bill would require hospitals to publish a consumer-friendly list of the standard charges for a total of 300 shoppable services. The list must include the price for each item and service, including any current payer-specific negotiated charges, the maximum and minimum negotiated prices, and the discounted price. If hospitals fail to comply, they would be subjected to a fine, and the government would publish a list of those hospitals violating the law.
Their bill would also apply price transparency rules to health insurance plans, including plans in the individual market, as well as the small and large group markets. In other words, insurers would be required to provide the public with pricing information on benefits and services, including the in-network rates, the maximum allowed amount, and the amount of cost sharing for each item or service. Price transparency requirements would also apply to clinical laboratory tests, Medicare Advantage plans, Medicare prescription drug plans, and pharmacy benefit managers (PBMs).
This legislation is a good start. A robust price transparency policy could deliver significant health care savings. Writing in Inquiry, the Journal of Health Care Organization, Provision and Financing, Professor Stephen Parente of the University of Minnesota estimates that transparency for hospital and insurance pricing could potentially achieve an annual savings pf $80.7 billion in 2025, resulting in a 6.9 percent reduction medical spending for all privately insured persons. Low-income Americans would enjoy the greatest benefit.
Under Section 302 of The Patient Act, the authors also touch on the anti-competitive payment structure that benefits hospitals over patients. The bill stipulates that Medicare (beneficiaries and federal taxpayers) would pay no more for physician-administered drugs delivered in a hospital setting than in a doctor’s office. This would help establish wider site neutrality in Medicare payment, which would, in turn, start to create a level playing field for serious market competition between giant hospital corporations and independent medical practices. And more competition, of course means lower costs.
All of this would save a lot of money in the healthcare sector. According to a recent study conducted on behalf of the Blue Cross Blue Shield Association, comprehensive Medicare site neutrality would yield a total savings of $471 billion over ten years, including a reduction of $117 billion in private health insurance premiums.
It could also achieve serious financial advantages for consumers on the ground. Writing in JAMA Network, a team of academicians recently examined comparative pricing for a set of shoppable medical procedures delivered by 1116 conventional hospitals and 156 physician-owned hospitals in the same geographic areas. They found that the physician-owned hospitals were able to deliver the same services at prices that were approximately one-third lower than conventional hospitals. A stunning performance.
But there is one big problem: Medicare patients today cannot take full advantage of physician owned hospitals, despite their superior record in providing high quality and cost- effective care. With the Affordable Care Act (ACA), Congress and the Obama administration restricted Medicare and Medicaid reimbursement for these innovative facilities; an anti-competitive measure that undercuts seniors access to high quality and specialized hospital care.
It is past time to reverse this costly and outdated policy. And Congress should build on its recent momentum to turbo-charge its health care price transparency agenda.
One big idea the House should consider to accelerate the impact of price transparency is a “shared savings” program. Simply put, if an insured patient with several options for a medical service chooses a low-cost option, the insurance company would share the savings from that choice, say 50/50, with the patient.
In short, the insurance company would give the patient a tax-free rebate, which he could, if he wished, deposit in a health savings account. Such a program would harness the economic incentives of both patients and health insurers in securing cost- effective care, while intensifying competition among medical professionals in delivering high quality care at competitive prices.
If their record so far is any indication, the 118th Congress is well on its way to making serious progress on health care reform. They deserve credit, and more importantly, they deserve our support. After all, there is still much more to be done.
Robert E. Moffit, PhD., is a Senior Fellow, and Mary McCloskey is a Research Assistant, in the Center for Health and Welfare Studies at The Heritage Foundation.
Morning Brew's take on an earlier congressional hearing about insulin prices.
This article was previously posted in the Following Pharma section header.
"Executives from top insulin makers Eli Lilly and Company, Novo Nordisk, and Sanofi testified alongside the three largest pharmacy benefit managers (PBMs)—CVS Health, Optum Rx, and Express Scripts—in a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing Wednesday over the drug’s increasing prices.
The hearing provided few solutions on how to make insulin more affordable, as the pharma executives and PBMs blamed each other for the high drug prices, echoing arguments made in 2019 that brought the same companies in front of Congress.
“If somebody in the real world is watching this hearing, they have heard every single person from the drug companies and from the PBMs say, ‘We are working tirelessly to lower the cost of prescription drugs, just knocking our brains out.’ And yet, at the end of the day, 1.3 million Americans are rationing their insulin,” HELP Committee Chairman Sen. Bernie Sanders said in the hearing Wednesday.
The insulin makers argued that higher rebate demands from PBMs have pushed list prices up. Drug manufacturers give PBMs rebates in exchange for preferential placement on a health plan’s list of approved medications. For every $1 increase in rebates, the list price of a prescription drug goes up $1.17 on average, according to a 2020 study from the University of Southern California."
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























